title: Luteinizing hormone secretion elicited in a ligand-independent activation of progesterone receptor manner at pituitary level in the rat: differential effect of two selective estrogen receptor modulators.
abstract: In the absence of progesterone, RU486 reduced basal and luteinizing hormone-releasing hormone (LHRH)-stimulated LH secretion in pituitaries from proestrous rats, a fact which evidences a ligand-independent activation of progesterone receptors (LIAPR) at pituitary level. This was also observed in pituitaries from rats treated with tamoxifen, and absent in glands from either ovariectomized or raloxifene-treated animals. Both ovariectomy or raloxifene treatment reduced the stimulatory effect of LHRH on LH secretion, while tamoxifen induced an even higher response. Prolactin (PRL) secretion was unaffected by either RU486 or LHRH, nor it was influenced by ovariectomy or raloxifene treatment. However, treatment with tamoxifen elevated PRL in all groups. These findings indicate that LIAPR is an estrogen-dependent phenomenon at the anterior pituitary of the female rat, and that tamoxifen and raloxifene present agonist and antagonist estrogen activity, respectively, at this level.
authors.affiliation: Department of Cell Biology, Physiology and Immunology, University of Córdoba School of Medicine, Córdoba, Spain.
authors.forename: D
authors.initials: D
authors.lastname: González
authors.forename: C
authors.initials: C
authors.lastname: Bellido
authors.forename: R
authors.initials: R
authors.lastname: Aguilar
authors.forename: J C
authors.initials: JC
authors.lastname: Garrido-Gracia
authors.forename: G
authors.initials: G
authors.lastname: Hernández
authors.forename: R
authors.initials: R
authors.lastname: Alonso
authors.forename: J E
authors.initials: JE
authors.lastname: Sánchez-Criado
mesh_terms: D000818:Animals; D020847:Estrogen Receptor Modulators / Q000494:pharmacology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000378:metabolism*; D015735:Mifepristone / Q000494:pharmacology; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism; D020849:Raloxifene Hydrochloride / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011980:Receptors, Progesterone / Q000378:metabolism*; D013629:Tamoxifen / Q000494:pharmacology
chemical_list: D020847:Estrogen Receptor Modulators; D011980:Receptors, Progesterone; D013629:Tamoxifen; D015735:Mifepristone; D007987:Gonadotropin-Releasing Hormone; D020849:Raloxifene Hydrochloride; D011388:Prolactin; D007986:Luteinizing Hormone